MMP9 and coronary artery disorder: The inflammatory response is one major pathway that contributes to the development of CHD; in this state, the level of cytokines, such as interleukin and C-reactive protein in the plasma, is significantly higher in individuals diagnosed with CHD [23], and the plasma matrix metalloproteinase-9 is an inflammatory marker that can serve as a predictor of CHD development [24].